摘要
背景:液体活检是一种检测体液中miRNA和无细胞DNA等分子生物标志物的微创检测方法。甲状腺乳头状癌(PTC)是最常见的内分泌恶性肿瘤之一。甲状腺乳头状癌中最常见的突变是BRAF突变。许多研究表明BRAF突变与miRNA的解除调控有关。p53在细胞周期调控、DNA修复和凋亡中具有重要作用。此外,p53还能调节miRNAs的表达,从而参与甲状腺癌的发生。目的:简要总结PTC发病过程中miRNA、BRAF和p53突变的研究现状,以及在液体活检中检测BRAF突变和miRNA表达的可能性。结果:血浆miRNA表达谱与cf-DNA BRAF突变分析相结合,可作为治疗PTC的一种有价值的工具。结论:多种分子变异表征了甲状腺癌的近期诊断、预后指标和治疗靶点,为甲状腺癌创新治疗策略的进一步研究和临床开发提供了独特的机会。
关键词: miRNA,甲状腺乳头状癌,液体活检,BRAF突变,MAPK通路,肿瘤蛋白p53,cf-DNA。
图形摘要
Current Drug Targets
Title:Potential of Liquid Biopsy in Papillary Thyroid Carcinoma in Context of miRNA, BRAF and p53 Mutation
Volume: 19 Issue: 14
关键词: miRNA,甲状腺乳头状癌,液体活检,BRAF突变,MAPK通路,肿瘤蛋白p53,cf-DNA。
摘要: Background: Liquid biopsy is a minimally invasive detection method for molecular biomarkers such as miRNA and cell free DNA in body fluids. Deregulations of miRNA are involved in papillary thyroid carcinoma (PTC), one the most common endocrine malignancy. The most widespread common mutations detected in papillary thyroid cancers are BRAF mutations. Many studies indicate that the BRAF mutation is related to deregulation of miRNA. p53 has an important role in cell cycle control, DNA repair and apoptosis. Moreover, the p53 can regulate the expression of miRNAs and thus participate in thyroid oncogenesis.
Objective: In this review, we briefly summarize the present state of knowledge about miRNA, BRAF and p53 mutation in the development of PTC and the possibility of using detecting BRAF mutation and miRNA expression in liquid biopsy.
Results: The use of the plasma miRNA expression profile in combination with the BRAF mutation analysis in cf-DNA may be a valuable tool in management of PTC.
Conclusion: Numerous molecular variation characterize recent diagnostic and prognostic markers and therapeutic targets for this type of cancer, which offer unique chances for further research and clinical development of innovative treatment strategies for thyroid cancer.
Export Options
About this article
Cite this article as:
Potential of Liquid Biopsy in Papillary Thyroid Carcinoma in Context of miRNA, BRAF and p53 Mutation, Current Drug Targets 2018; 19 (14) . https://dx.doi.org/10.2174/1389450119666180226124349
DOI https://dx.doi.org/10.2174/1389450119666180226124349 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Physiological and Pathophysiological Functions of SIRT1
Mini-Reviews in Medicinal Chemistry Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Current Pharmaceutical Design PET and PET/CT: Conceptions, Misconceptions, and a Potential New Paradigm for Enhanced Metabolic Imaging
Current Medical Imaging Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer
Current Medicinal Chemistry Functions of Antimicrobial Peptides in Vertebrates
Current Protein & Peptide Science Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer
Current Drug Targets - Immune, Endocrine & Metabolic Disorders The Flavin-Containing Monoooxygenases (FMOs): Genetic Variation and its Consequences for the Metabolism of Therapeutic Drugs
Current Pharmacogenomics The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy
Current Topics in Medicinal Chemistry Nuclear Receptors CAR and PXR in Metabolism and Elimination of Drugs
Current Pharmacogenomics 7-Difluoromethyl-5, 4’-Dimethoxygenistein Reverses LPC-Induced Apoptosis of HUVE-12 Cells Through Regulating Mitochondrial Apoptosis Pathway
Current Signal Transduction Therapy In Silico Studies Revealed Multiple Neurological Targets for the Antidepressant Molecule Ursolic Acid
Current Neuropharmacology Role of Antioxidants, Essential Fatty Acids, Carnitine, Vitamins, Phytochemicals and Trace Elements in the Treatment of Diabetes Mellitus and its Chronic Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets AIDS Related Viruses, their Association with Leukemia, and Raf Signaling
Current HIV Research Chemical Space of FLT3 Inhibitors as Potential Anti-AML Drugs
Recent Patents on Anti-Cancer Drug Discovery Activated Immune System and Inflammation in Healthy Ageing: Relevance for Tryptophan and Neopterin Metabolism
Current Pharmaceutical Design Enhancement of TLR-Mediated Innate Immune Responses by Peptidoglycans through NOD Signaling
Current Pharmaceutical Design Potential Use of Vanadium Compounds in Therapeutics
Current Medicinal Chemistry Cellular and Molecular Mechanisms of Curcumin in Thyroid Gland Disorders
Current Medicinal Chemistry Anticancer Chemodiversity of Ranunculaceae Medicinal Plants: Molecular Mechanisms and Functions
Current Genomics Cardiovascular and Metabolic Effects of Ghrelin
Current Diabetes Reviews